World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
34
Citations
5222
World Ranking
9316
National Ranking
16

Pavel Mareš publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Pavel Mareš sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 256 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Pavel Mareš D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Pavel Mareš sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 34 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Pavel Mareš is affiliated with the Czech Academy of Sciences in the Czech Republic. Their research primarily spans multiple disciplines, including neuroscience, medicine, and biochemistry, genetics, and molecular biology.

The scientist's work covers several interconnected fields of study, notably:

  • Neuroscience
  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these broader fields, their focus narrows to key subfields such as:

  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental Health
  • Molecular Biology
  • Cognitive Neuroscience
  • Pediatrics, Perinatology and Child Health

The primary topics addressed in their research include:

  • Neuroscience and Neuropharmacology Research
  • Epilepsy Research and Treatment
  • Ion Channel Regulation and Function
  • Memory and Neural Mechanisms
  • Adenosine and Purinergic Signaling
  • Cannabis and Cannabinoid Research
  • Lipid Membrane Structure and Behavior

Pavel Mareš has contributed to several respected scientific journals, including frequent publications in:

  • International Journal of Molecular Sciences
  • Pharmaceutics
  • Pharmaceuticals
  • Annals of Clinical and Translational Neurology
  • Epilepsia Open

The scientist has coauthored papers with multiple researchers, with notable collaboration counts including:

  • Hana Kubová (13 papers)
  • Grygoriy Tsenov (4 papers)
  • Libor Uttl (3 papers)
  • Eva Kudová (3 papers)
  • Anna Mikulecká (2 papers)

Examples of recent papers authored or coauthored by Pavel Mareš cover topics related to neuropharmacology and epilepsy, such as:

  • Radiprodil, a NR2B negative allosteric modulator, from bench to bedside in infantile spasm syndrome, 2020, Annals of Clinical and Translational Neurology
  • The GluN2B-Selective Antagonist Ro 25-6981 Is Effective against PTZ-Induced Seizures and Safe for Further Development in Infantile Rats, 2021, Pharmaceutics
  • Anticonvulsive Effects and Pharmacokinetic Profile of Cannabidiol (CBD) in the Pentylenetetrazol (PTZ) or N-Methyl-D-Aspartate (NMDA) Models of Seizures in Infantile Rats, 2021, International Journal of Molecular Sciences
  • The Neuroactive Steroid Pregnanolone Glutamate: Anticonvulsant Effect, Metabolites and Its Effect on Neurosteroid Levels in Developing Rat Brains, 2021, Pharmaceuticals
  • Neonatal Clonazepam Administration Induced Long-Lasting Changes in GABAA and GABAB Receptors, 2020, International Journal of Molecular Sciences

Best Publications

  • Status epilepticus in immature rats leads to behavioural and cognitive impairment and epileptogenesis.

    Hana Kubová;Pavel Mareš;Lucie Suchomelová;Gustav Brožek

  • Pentylenetetrazol-induced seizures in rats: an ontogenetic study.

    L Velisek;H Kubova;H Kubova;M Pohl;M Pohl;L Stankova

  • N-methyl-D-aspartate (NMDA)-induced seizures in developing rats.

    Pavel Mareš;Pavel Mareš;Libor Velišek;Libor Velišek

  • Seizures Induced by Homocysteine in Rats During Ontogenesis

    H. Kubová;J. Folbergrová;P. Mareš;P. Mareš

  • Ketamine suppresses both bicuculline- and picrotoxin-induced generalized tonic-clonic seizures during ontogenesis

    J. Velíšková;L. Velíšek;L. Velíšek;P. Mareš;P. Mareš;R. Rokyta

  • Cognitive functions after pilocarpine-induced status epilepticus: changes during silent period precede appearance of spontaneous recurrent seizures.

    Jakub Hort;Gustav Brozek;Gustav Brozek;Pavel Mares;Milos Langmeier

  • Effects of flunarizine on Metrazol-induced seizures in developing rats

    Unknown

  • Different effects of two N-methyl-D-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats.

    Pavel Mareš;Anna Mikulecká

  • Behavioral and metabolic changes in immature rats during seizures induced by homocysteic acid : the protective effect of NMDA and non-NMDA receptor antagonists

    Jaroslava Folbergrová;Renata Haugvicová;Pavel Mareš

  • NMDA and AMPA receptors: development and status epilepticus.

    Szczurowska E;Mareš P

  • Anticonvulsant Action of Oxcarbazepine, Hydroxycarbamazepine, and Carbamazepine Against Metrazol-Induced Motor Seizures in Developing Rats

    H Kubová;P Mares;P Mares

  • Long-term behavioral and morphological consequences of nonconvulsive status epilepticus in rats

    Pavel Kršek;Anna Mikulecká;Rastislav Druga;Hana Kubová

  • Convulsant Action of D,L‐Homocysteic Acid and Its Stereoisomers in Immature Rats

    Pavel Mares;J Folbergrova;M Langmeier;R Haugvicova

  • Epilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2)

    Amos D. Korczyn;Steven C. Schachter;Martin J. Brodie;Sarang S. Dalal;Sarang S. Dalal

  • Correlation between electrocorticographic and motor phenomena induced by pentamethylenetetrazol during ontogenesis in rats.

    Renée Schickerová;Renée Schickerová;Pavel Mareš;Pavel Mareš;Stanislav Trojan;Stanislav Trojan

  • Neuronal cell death in hippocampus induced by homocysteic acid in immature rats.

    Miloš Langmeier;Jaroslava Folbergrová;Renata Haugvicová;Jaroslav Pokorný

  • Interstrain differences in cognitive functions in rats in relation to status epilepticus.

    J Hort;G Brožek;V Komárek;M Langmeier

  • Unequal development of thresholds for various phenomena induced by cortical stimulation in rats.

    Pavel Mareš;Renata Haugvicová;Hana Kubová

  • Attenuation of seizures induced by homocysteic acid in immature rats by metabotropic glutamate group II and group III receptor agonists.

    Jaroslava Folbergrová;Renata Haugvicová;Pavel Mareš

  • Seizures induced in immature rats by homocysteic acid and the associated brain damage are prevented by group II metabotropic glutamate receptor agonist (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate.

    Jaroslava Folbergrová;Rastislav Druga;Jakub Otáhal;Renata Haugvicová

  • Seizures induced by homocysteic acid in immature rats are prevented by group III metabotropic glutamate receptoragonist (R,S)-4-phosphonophenylglycine

    Jaroslava Folbergrová;Renata Haugvicová;Pavel Mareš

Frequent Co-Authors

Ivan Rektor
Ivan Rektor Masaryk University
Sarang S. Dalal
Sarang S. Dalal Aarhus University
Antonio Ferrante
Antonio Ferrante University of Adelaide
Gilles van Luijtelaar
Gilles van Luijtelaar Radboud University
Philippe Ryvlin
Philippe Ryvlin University Hospital of Lausanne
Jana Velíšková
Jana Velíšková New York Medical College
Stefano Meletti
Stefano Meletti University of Modena and Reggio Emilia
Karim Jerbi
Karim Jerbi University of Montreal
Philip N. Patsalos
Philip N. Patsalos University College London
Pierandrea Muglia
Pierandrea Muglia UCB Pharma (Belgium)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are exploring a future in Neuroscience, there are several online education pathways to consider. For those eager to enter the workforce quickly, you might look into 2 year accelerated bachelor degrees online. These programs are designed for focused, motivated students and offer a faster route to graduation without sacrificing education quality.

Career prospects in Neuroscience are often tied to the right degree. Pursuing high paying degrees can maximize your future earning potential. For students seeking a balance of academic rigor and financial reward, you may want to investigate easiest college majors with high pay in related scientific or technical fields.

Cost is another major consideration. When searching for affordable and reputable programs, you can review options like the cheapest online college that accept FAFSA, to help ease your financial burden. By combining the right program format and funding options, you can make your Neuroscience career goals both attainable and sustainable.

Best Scientists Citing Pavel Mareš

Trending Scientists

Recently Published Articles